Different Wording of the Patient Global Visual Analogue Scale (PG-VAS) Affects Rheumatoid Arthritis Patients' Scoring and the Overall Disease Activity Score (DAS28): A Cross-Sectional Study

Musculoskeletal Care

Volumn 11, Issue 4, 2013, Pages 229-237

  French, Tracy ^a   Hewlett, Sarah ^b   Kirwan, John ^c   Sanderson, Tessa ^b  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

DAS28; Outcomes research; Patient perspective; Rheumatoid arthritis

Indexed keywords

ADULT; AGED; ARTHRALGIA; ARTICLE; CROSS-SECTIONAL STUDY; DAS28; EMOTION; FEMALE; HEALTH STATUS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PAIN ASSESSMENT; PATIENT PERSPECTIVE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SEVERITY OF ILLNESS INDEX;

DAS28; OUTCOMES RESEARCH; PATIENT PERSPECTIVE; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRALGIA; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; EMOTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN MEASUREMENT; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84889659527     PISSN: 14782189     EISSN: 15570681     Source Type: Journal    
DOI: 10.1002/msc.1046     Document Type: Article

References (34)

1. Aletaha D, Nell VP, Stamm T, Uffman M, Pflugbeil S, Machold K, Smolen JS (2005). Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: Validation of a clinical activity score. Arthritis Research & Therapy 7: R796-806.
2. Bakker MF, Jacobs JWG, Welsing PMJ, Verstappen SMM, Tekstra J, Ton E Geurts MAZ, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FPJG, Bijlsma JWJ, on behalf of the Utrecht Rheumatoid Arthritis Cohort Study Group (2012). Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis. Annals of Internal Medicine 156: 329-39.
3. Bland JM, Altman DG (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 8476: 307-10.
4. British Society for Rheumatology Biologics Register (2009). 28-Joint Swollen and Tender Joint Count. Available at http://www.medicine.manchester.ac.uk/images/File/RA28.pdf [Accessed 28 April 2009].
5. DAS Group (2001). Disease Activity Score in Rheumatoid Arthritis. Available at http://www.das-score.nl/das28/en/ [Accessed 16 January 2013].
6. Dougados M, Ripert M, Hilliquin P, Fardellone P, Brocq O, Brault Y, Logeart I (2011). The influence of the definition of patient global assessment in disease activity according to the Disease Activity Score (DAS28) in assessment of rheumatoid arthritis. Journal of Rheumatology 38: 2326-8.
7. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams HJ, Wolfe F, Kieszak S (1995). American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism 38: 727-35.
8. Felson D, Smolen J, Wells G, Zhang B, van Tuyl LHD, Funovits J, Aletaha D, Allaart C F, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M, Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewé R, Listing J, Michaud K, Martin-Mola E, Montie P, Pincus T, Richards P, Siegel JN, Simon L S, Sokka T, Strand V, Tugwell P, Tyndall A, van der Heijde D, Verstappen S, White B, Wolfe F, Zink A, Boers M (2011). American College of Rheumatology/European League Against Rheumatology provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis and Rheumatism 63: 573-86.
9. Fries JF, Ramey DR (1997). 'Arthritis specific' global health analog scales assess 'generic' health related quality-of-life in patients with rheumatoid arthritis. Journal of Rheumatology 24: 1697-702.
10. Fries JF, Spitz PW, Kraines RG, Holman HR (1980). Measurement of patient outcome in arthritis. Arthritis and Rheumatism 23: 137-45.
11. van Gestel AM, van Riel PLCM (1997). Evaluation of early rheumatoid arthritis disease activity and outcome. Baillière's Clinical Rheumatology 11: 49-63.
12. van Gestel AM, Haagsma CJ, van Riel PLCM (1998). Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis and Rheumatism 41: 1845-50.
13. van Gestel AM, Prevoo MLL, van 'T Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996). Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Arthritis and Rheumatism 39: 34-40.
14. Harrison M, Boonen A, Tugwell P, Symmons D (2009). Same question, different answers: A comparison of global health assessments using VAS scales. Quality of Life Research 18: 1285-92.
15. van der Heidje DM, van't Hof MA, van Riel PLCM, van de Putte LB (1993). Development of a disease activity score based on judgement of clinical practice by rheumatologists. Journal of Rheumatology 20: 579-81.
16. van der Heijde DM (1998). The original 'DAS' and the 'DAS28' are not interchangeable: Comment on the articles by Prevoo et al. Arthritis and Rheumatism 41: 942-3.
17. van der Heijde DM, van't Hof MA, van Riel PLCM, van de Putte LB (1992). Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Annals of the Rheumatic Diseases 51: 177-81.
18. Hewlett S, Sanderson T, May J, Alten R, Bingham III CO, Cross M, March L, Pohl C, Woodworth T, Bartlett S (2012). 'I'm hurting, I want to kill myself': Rheumatoid arthritis flare is more than a high joint count-An international patient perspective on flare where medical help is sought. Rheumatology 51: 69-76.
19. Kalyoncu U, Dougados M, Daures JP, Gossec L (2009). Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Annals of the Rheumatic Diseases 8: 183-90.
20. Masri KR, Shaver TS, Shahouri SH Wang S, Anderson JD, Busch RE, Michaud K, Mikuls TR, Caplan L, Wolfe F (2012). Validity and reliability problems with patient global as a component of the ACR/EULAR remission criteria as used in clinical practice. Journal of Rheumatology 39: 1139-45.
21. Meenan RF, Gertman PM, Mason JH (1980). Measuring health status in arthritis: The arthritis impact measurement scales. Arthritis and Rheumatism 23: 146-52.
22. National Institute for Health and Clinical Excellence (2007). Adalimumab, Etanercept and Infliximab for the Treatment of Rheumatoid. Technology Appraisal Guidance No. 130. London: National Institute for Health and Clinical Excellence (Reviewed 2010).
23. Porter D, Gadsby K, Thompson P, White J, McClinton C, Oliver S (2011). DAS28 and rheumatoid arthritis: The need for standardization. Musculoskeletal Care 9: 222-7.
24. Prevoo MLL, van't Hof MA, Kupper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995). Modified disease activity scores that include twenty-eight-joint counts. Arthritis and Rheumatism 38: 44-8.
25. Sanderson T, Hewlett S, Flurey C, Dures E, Richards P, Kirwan J (2011). The impact triad (incorporating severity, importance and self-management) as a method of enhancing the measurement of the personal life impact of rheumatic diseases. Journal of Rheumatology 38: 191-4.
26. Sanderson T, Morris M., Calnany M, Richards P., Hewlett S (2009). Rheumatoid Arthritis Patients' Interpretation of the DAS Patient Global Used at Bristol Royal Infirmary. Arthritis & Rheumatism 60: 1207.
27. Scott DL, van Riel PLCM, van der Heijde DM, Benke AS (1993). Assessing Disease Activity in Rheumatoid Arthritis: The EULAR Handbook of Standard Methods. Zurich: EULAR.
28. Smedstad LM, Kvien TK, Moum T, Vaglum P (1997). Correlates of patients' global assessment of arthritis impact. Scandinavian Journal of Rheumatology 26: 259-65.
29. Smith N, Gadsby K, Butt S, Carruthers D, Deeming A, Ledingham J, Fletcher M, Mulherin D, Roskell S, Kay L, Nicholl K, Cooper R, Worsley A, Deighton C (2007). Is pre-assessment for anti-TNF therapy in RA necessary in the UK? Analysis of DAS28 in six centres. Rheumatology 46: 1557-9.
30. Smolen J, Landewe R, Breedveld F, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D (2010). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease modifying antirheumatic drugs. Annals of the Rheumatic Diseases 69: 964-75.
31. Studenic P, Radner H, Smolen JS, Aletaha D (2012). Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity. Arthritis and Rheumatism 64: 2814-23.
32. van Tuyl LHD, Boers M (2012). Patient's global assessment of disease activity: What are we measuring? [Editorial]. Arthritis and Rheumatism 64: 2811-2.
33. Uhlig T, Moe R, Reinsberg S, Kvien TK, Cieza A, Stucki G (2009). Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis. Annals of the Rheumatic Diseases 68: 879-84.
34. Wolfe F, Michaud K (2009). Proposed metrics for the determination of rheumatoid arthritis outcome and treatment success and failure. Journal of Rheumatology 36: 27-33.